Regeneron denied safe harbour defence in COVID-19 drug dispute

Judge says use of patented protein mNeonGreen not covered by Section 271(e)(1) provision I Allele granted summary judgment in patent infringement suit.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Biotechnology

Allele drops COVID-19 protein suit against Pfizer, BioNTech

6 January 2022 Biotech Allele has dropped its lawsuit accusing Pfizer and BioNTech of infringing technology covering a fluorescent protein used in COVID-19 vaccines.

Big Pharma

Regeneron can’t dodge Allele’s COVID patent suit

7 March 2022 Regeneron has failed to convince a Manhattan district court to drop a lawsuit claiming that it developed COVID-19 treatments using Allele’s fluorescent protein invention without its permission.

More on this story

Biotechnology

Allele drops COVID-19 protein suit against Pfizer, BioNTech

6 January 2022 Biotech Allele has dropped its lawsuit accusing Pfizer and BioNTech of infringing technology covering a fluorescent protein used in COVID-19 vaccines.

Big Pharma

Regeneron can’t dodge Allele’s COVID patent suit

More on this story

Biotechnology

Allele drops COVID-19 protein suit against Pfizer, BioNTech

6 January 2022 Biotech Allele has dropped its lawsuit accusing Pfizer and BioNTech of infringing technology covering a fluorescent protein used in COVID-19 vaccines.

Big Pharma

Regeneron can’t dodge Allele’s COVID patent suit